Jane Street
KYMR icon

Jane Street’s Kymera Therapeutics KYMR Stock Holding History

Jane Street’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$245K Buy
+2,939
New +$233K ﹤0.01% 9676
2025
Q2 		– Sell
-65,399
Closed -$2.25M – 10318
2025
Q1 		$1.79M Buy
65,399
+48,635
+290% +$1.77M ﹤0.01% 4543
2024
Q4 		$674K Sell
16,764
-71,710
-81% -$3.24M ﹤0.01% 6132
2024
Q3 		$4.19M Sell
88,474
-1,654
-2% -$73K ﹤0.01% 3150
2024
Q2 		$2.69M Buy
90,128
+49,119
+120% +$1.7M ﹤0.01% 3988
2024
Q1 		$1.65M Sell
41,009
-154,958
-79% -$5.54M ﹤0.01% 4479
2023
Q4 		$4.99M Buy
195,967
+96,915
+98% +$1.73M ﹤0.01% 2855
2023
Q3 		$1.38M Sell
99,052
-36,572
-27% -$735K ﹤0.01% 4670
2023
Q2 		$3.12M Buy
135,624
+70,850
+109% +$2.03M ﹤0.01% 3427
2023
Q1 		$1.92M Sell
64,774
-5,223
-7% -$168K ﹤0.01% 3901
2022
Q4 		$1.75M Buy
69,997
+9,273
+15% +$247K ﹤0.01% 4061
2022
Q3 		$1.32M Buy
+60,724
New +$1.6M ﹤0.01% 4921
2022
Q2 		– Sell
-13,470
Closed -$570K – 10341
2022
Q1 		$570K Buy
13,470
+6,666
+98% +$282K ﹤0.01% 7222
2021
Q4 		$432K Buy
6,804
+3,057
+82% +$178K ﹤0.01% 7524
2021
Q3 		$220K Buy
+3,747
New +$217K ﹤0.01% 8711
2021
Q2 		– Sell
-40,394
Closed -$1.57M – 10127
2021
Q1 		$1.57M Buy
40,394
+36,931
+1,066% +$2.22M ﹤0.01% 4493
2020
Q4 		$215K Buy
+3,463
New +$169K ﹤0.01% 6860

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Jane Street's KYMR Position: Q1 2026 in Review

Jane Street opened a new position in Kymera Therapeutics (KYMR) in Q1 2026: 2,939 shares worth $245K. The stake represents ﹤0.01% of the portfolio and ranks #9676 among its holdings. This is a return to the name: Jane Street previously reported a position in KYMR as recently as Q1 2025.

Jane Street first reported a position in KYMR in Q4 2020 and has held it in 17 quarters since. The position peaked at $4.99M in Q4 2023. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Jane Street held 2,939 shares of Kymera Therapeutics worth $245K as of Q1 2026.
  • Kymera Therapeutics was a new Jane Street position in Q1 2026.
  • Kymera Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #9676 holding.
  • Jane Street first reported a position in Kymera Therapeutics in Q4 2020 and has held it in 17 quarters since.
  • Jane Street's Kymera Therapeutics position peaked at $4.99M in Q4 2023.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.